ESR1 and breast carcinoma: Although reactivation of the p53 signaling pathway has been considered as a good breast cancer treatment strategy, there is growing evidence at the molecular level to suggest an association between ERα and p53, which protects breast cancer cells from dying [90,93,98,160,161,162,163].